Cinacalcet Improves Endothelial Dysfunction and Cardiac Hypertrophy in Patients on Hemodialysis with Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 1660-2110|122|1-2|1-8

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.122, Iss.1-2, 2013-03, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 2, 2010-08 ,pp. : c151-c159

Karger

Access to resources Recommend Favorite

Calcitriol Regresses Cardiac Hypertrophy and QT Dispersion in Secondary Hyperparathyroidism on Hemodialysis

By  

Nephron Clin Pract, Vol. 102, Iss. 1, 2005-09 ,pp. : c21-c29

Karger

Access to resources Recommend Favorite

Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism

By Kurajoh M.   Inaba M.   Okuno S.   Nagayama H.   Yamada S.   Imanishi Y.   Ishimura E.   Shoji S.   Yamakawa T.   Nishizawa Y.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 923-930

Springer Publishing Company

Access to resources Recommend Favorite

Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients

By Sharma Amit   Ketteler Markus   Marshall Thomas S.   Khan Samina S.   Schumock Glen T.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1129-1136

Informa Healthcare

Access to resources Recommend Favorite

Decreases in Parathyroid Gland Volume after Cinacalcet Treatment in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 115, Iss. 3, 2010-04 ,pp. : c195-c202

Karger

Access to resources Recommend Favorite